|
| 37880926 | Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. | Pediatr Blood Cancer | 2024 |
| 36828140 | Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials. | Radiother Oncol | 2023 |
| 37843857 | Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial. | Clin Cancer Res | 2023 |
| 37834840 | Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse. | J Clin Med | 2023 |
| 37813959 | Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study. | Br J Cancer | 2023 |
| 37725766 | Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry. | J Clin Oncol | 2023 |
| 35687182 | Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma. | J Cancer Res Clin Oncol | 2023 |
| 37046711 | Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. | Cancers (Basel) | 2023 |
| 37444475 | Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy. | Cancers (Basel) | 2023 |
| 37365178 | Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis. | Nat Commun | 2023 |
| 36854071 | Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial. | J Clin Oncol | 2023 |
| 36900410 | Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images. | Cancers (Basel) | 2023 |
| 34546642 | Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma. | Pediatr Blood Cancer | 2022 |
| 35441463 | Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults. | Pediatr Blood Cancer | 2022 |
| 35454826 | Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials. | Cancers (Basel) | 2022 |
| 35592976 | Factors Influencing Implementation of the Survivorship Passport: The IT Perspective. | Stud Health Technol Inform | 2022 |
| 35859155 | Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup. | Sci Rep | 2022 |
| 35619911 | No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy. | Front Oncol | 2022 |
| 36497417 | Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry. | Cancers (Basel) | 2022 |
| 35901818 | The impact of the EU General Data Protection Regulation on childhood cancer research in Europe. | Lancet Oncol | 2022 |
| 36101004 | Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. | Cancer | 2022 |
| 35954314 | Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images. | Cancers (Basel) | 2022 |
| 36011005 | Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results. | Cancers (Basel) | 2022 |
| 35205646 | Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol. | Cancers (Basel) | 2022 |
| 34636137 | Infantile myofibromatosis: Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. | Pediatr Blood Cancer | 2022 |
| 33205902 | A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project. | Pediatr Blood Cancer | 2021 |
| 33540616 | Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94. | Cancers (Basel) | 2021 |
| 33640061 | Continue rare cancers collaboration with European Reference Networks after Brexit. | Lancet | 2021 |
| 33913610 | The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in children. | Pediatr Blood Cancer | 2021 |
| 34500044 | Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2021 |
| 34503120 | Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging. | Cancers (Basel) | 2021 |
| 34272609 | The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents. | J Cancer Res Clin Oncol | 2021 |
| 34152804 | Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study. | J Clin Oncol | 2021 |
| 34115544 | Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). | J Clin Oncol | 2021 |
| 34089219 | Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS). | Pediatr Blood Cancer | 2021 |
| 33316634 | Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience. | Eur J Cancer | 2021 |
| 33252831 | Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets. | Mol Oncol | 2021 |
| 31580267 | Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial. | Clin Orthop Relat Res | 2020 |
| 31932909 | Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS). | J Cancer Res Clin Oncol | 2020 |
| 31753608 | The impact of local control in the treatment of children with advanced infantile and adult-type fibrosarcoma: Experience of the cooperative weichteilsarkom studiengruppe (CWS). | J Pediatr Surg | 2020 |
| 32013055 | Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1). | Cancers (Basel) | 2020 |
| 31736251 | Low-grade fibromyxoid sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS). | Pediatr Blood Cancer | 2020 |
| 32599807 | Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review. | Cancers (Basel) | 2020 |
| 32903140 | Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable <i>MYCN</i>-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group. | J Clin Oncol | 2020 |
| 32812260 | Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. | J Surg Oncol | 2020 |
| 32639845 | Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study. | J Clin Oncol | 2020 |
| 32246291 | PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers. | Eur Radiol Exp | 2020 |
| 32472746 | The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. | Pediatr Blood Cancer | 2020 |
| 30652419 | Desmoplastic small round cell tumors: Multimodality treatment and new risk factors. | Cancer Med | 2019 |
| 31741754 | Low CD4âº/CD25âº/CD127â» regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2. | Oncoimmunology | 2019 |